Diederick Grobbee
Overview
Explore the profile of Diederick Grobbee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
4262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Majani N, Sharau G, Mlawi V, Kalezi Z, Mongella S, Letara N, et al.
BMC Cardiovasc Disord
. 2024 Sep;
24(1):493.
PMID: 39277731
Background: Tetralogy of Fallot (TOF) is typically treated in infancy but often done late in many resource-limited countries, jeopardizing surgical outcomes. This study examined the early results of children undergoing...
2.
Rodgers A, Salam A, Schutte A, Cushman W, de Silva H, Di Tanna G, et al.
J Am Coll Cardiol
. 2024 Sep;
84(24):2393-2403.
PMID: 39217570
Background: Single-pill combinations of 3 or more low-dose blood pressure (BP)-lowering drugs hold promise for initial or early treatment of hypertension. Objectives: The authors conducted a placebo-controlled trial of a...
3.
Kuiper M, Douglas S, Keunen J, Voogdt-Pruis H, van der Ven L, Grobbee D, et al.
PLoS One
. 2024 Jul;
19(7):e0305262.
PMID: 38990934
Advancing public health through prevention necessitates collaboration among public, private, and community actors. Only together can these different actors amass the resources, knowledge, and community outreach required to promote health....
4.
Nyame S, Boateng D, Heeres P, Gyamfi J, Gafane-Matemane L, Amoah J, et al.
Glob Heart
. 2024 Jun;
19(1):51.
PMID: 38883258
Background: Individuals living with hypertension are at an increased risk of cardiovascular- and cerebrovascular-related outcomes. Interventions implemented at the community level to improve hypertension control are considered useful to prevent...
5.
Rodgers A, Salam A, Cushman W, de Silva A, Di Tanna G, Gnanenthiran S, et al.
Glob Heart
. 2024 Feb;
19(1):18.
PMID: 38371656
Two recent large trials showed the potential of single pill combinations (SPCs) with ≥3 low-dose components among people with hypertension who were untreated or receiving monotherapy. In both trials, these...
6.
Laurijssen S, van der Graaf R, Schuit E, den Haan M, van Dijk W, Groenwold R, et al.
Learn Health Syst
. 2024 Jan;
8(1):e10379.
PMID: 38249849
Background: Implementation of an LHS in cardiology departments presents itself with ethical challenges, including ethical review and informed consent. In this qualitative study, we investigated stakeholders' attitudes toward ethical issues...
7.
Ishaku S, Adu-Bonsaffoh K, Housseine N, Lamptey R, Franx A, Grobbee D, et al.
Glob Heart
. 2023 May;
18(1):21.
PMID: 37125389
Hypertensive disorders in pregnancy (HDP) and cardiometabolic and kidney diseases are rising in low- and middle-income countries (LMICs). While HDP are risk factors for cardiometabolic and kidney diseases, cost-effective, scalable...
8.
Boateng D, Kumke T, Vernooij R, Goetz I, Meinecke A, Steenhuis C, et al.
Contemp Clin Trials
. 2022 Dec;
125:107054.
PMID: 36529438
Background: The GetReal Trial Tool is a decision support tool to assess the impact of design choices on generalizability of clinical trials to routine clinical practice, while taking into account...
9.
Nonterah E, Boateng D, Crowther N, Klipstein-Grobusch K, Oduro A, Agongo G, et al.
JAMA Netw Open
. 2022 Apr;
5(4):e227559.
PMID: 35471573
Importance: Carotid atherosclerosis and microalbuminuria are associated with atherosclerotic cardiovascular disease (ASCVD) but are understudied in sub-Saharan Africa. Objective: To evaluate the association of carotid atherosclerosis and microalbuminuria with 10-year...
10.
De Backer G, Perk J, Wood D, Gielen S, Pelliccia A, Grobbee D, et al.
Eur J Prev Cardiol
. 2022 Feb;
29(9):1301-1308.
PMID: 35148371
No abstract available.